Related Experiment Video
Updated: Feb 16, 2026

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
Published on: May 2, 2017
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Kristoffer Unterbruner1, Frank Matthes1, Judith Schilling1
1Regulatory RNA-protein interactions in neurodegenerative diseases, German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany.
Abstract:
The MID1 ubiquitin ligase activates mTOR signaling and regulates mRNA translation. Misregulation of MID1 expression is associated with various diseases including midline malformation syndromes, cancer and neurodegenerative diseases. While this indicates that MID1 expression must be tightly regulated to prevent disease states specific mechanisms involved have not been identified. We examined miRNAs to determine mechanisms that regulate MID1 expression. MicroRNAs (miRNA) are small non-coding RNAs that recognize specific sequences in their target mRNAs. Upon binding, miRNAs typically downregulate expression of these targets. Here, we identified four miRNAs, miR-19, miR-340, miR-374 and miR-542 that bind to the 3'-UTR of the MID1 mRNA. These miRNAs not only regulate MID1 expression but also mTOR signaling and translation of disease associated mRNAs and could therefore serve as potential drugs for future therapy development.
Insights
This study identifies four microRNAs (miRNAs) that regulate MID1 expression, a key factor in mTOR signaling and mRNA translation. These miRNAs offer potential therapeutic targets for diseases linked to MID1 misregulation.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MID1 ubiquitin ligase activates mTOR signaling and regulates mRNA translation.
- Misregulated MID1 expression is implicated in midline malformation syndromes, cancer, and neurodegenerative diseases.
- Specific regulatory mechanisms for MID1 expression remain largely unidentified.
Purpose of the Study:
- To investigate microRNAs (miRNAs) as potential regulators of MID1 expression.
- To identify specific miRNAs that target the MID1 mRNA.
- To explore the therapeutic potential of these miRNAs in diseases associated with MID1 dysregulation.
Main Methods:
- Bioinformatic analysis to predict miRNA binding sites on MID1 mRNA.
- Experimental validation of miRNA-target interactions.
- Assessment of miRNA effects on MID1 expression, mTOR signaling, and mRNA translation.
Main Results:
- Four miRNAs (miR-19, miR-340, miR-374, and miR-542) were identified as binding to the 3'-UTR of MID1 mRNA.
- These miRNAs were shown to downregulate MID1 expression.
- The identified miRNAs also impacted mTOR signaling and the translation of disease-associated mRNAs.
Conclusions:
- Specific miRNAs play a crucial role in regulating MID1 expression and downstream signaling pathways.
- These miRNAs represent novel therapeutic targets for diseases linked to MID1 misregulation.
- Targeting these miRNAs could offer a new strategy for treating various cancers and neurodegenerative disorders.
Related Concept Videos
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

